Integrin targeted imaging agents
View Patent ↗Emulsions preferably of nanoparticles formed from high boiling liquid perfluorochemical substances, said particles coated with a lipid/surfactant coating are made specific to regions of activated endothelial cells by coupling said nanoparticles to a ligand specific for α v β 3 integrin, other than an antibody. The nanoparticles may further include biologically active agents, radionuclides, or other imaging agents.
1. A composition comprising an emulsion of nanoparticles, wherein said nanoparticles consist of liquid perfluorocarbon cores coated with lipid/surfactant, and
wherein said nanoparticles are coupled to a ligand specific for α v β 3 , which comprises the formula
and wherein the coupling of said nanoparticles to the ligand is through a covalent linkage, through a spacer, to a component of the lipid/surfactant coating, and
wherein said nanoparticles incorporate at least one imaging agent.
2. The composition of claim 1 , wherein said residue is coupled through the spacer to a component of the lipid/surfactant coating that is a phosphatidyl lipid.
3. The composition of claim 2 , wherein the ligand coupled to the component of the lipid/surfactant coating is of the formula
4. The composition of claim 1 , wherein said imaging agent is a radioisotope.
5. The composition of claim 1 , wherein the imaging agent is a fluorophore.
6. The composition of claim 1 , wherein the imaging agent is a magnetic resonance imaging (MRI) contrast agent.
7. The composition of claim 6 , wherein said MRI contrast agent is a chelated paramagnetic ion.
8. The composition of claim 7 , wherein the paramagnetic ion is gadolinium ion.
9. The composition of claim 1 , which further contains a biologically active agent.
10. The composition of claim 9 , wherein said biologically active agent is a hormone or pharmaceutical.
11. The composition of claim 10 , wherein the pharmaceutical compound is an antineoplastic agent, an analgesic, an anesthetic, a neuromuscular blocker, an antimicrobial agent, an antiparasitic agent, an antiviral agent, an interferon, an antidiabetic, an antihistamine, an antiitussive, or an anticoagulant, or an antiproliferative.
12. The composition of claim 11 , wherein the pharmaceutical compound is an antiproliferative.
13. The composition of claim 12 , wherein the pharmaceutical compound is paclitaxel or rapamycin.